China SXT Pharmaceuticals, Inc.
SXTC
$4.13
$0.8325.15%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.21M | -7.54M | -8.87M | -6.09M | -3.30M |
| Total Depreciation and Amortization | 143.40K | 129.40K | 115.40K | 133.60K | 151.80K |
| Total Amortization of Deferred Charges | -- | 216.20K | 432.40K | 476.60K | 520.80K |
| Total Other Non-Cash Items | 4.43M | 5.62M | 6.80M | 4.03M | 1.26M |
| Change in Net Operating Assets | -2.39M | -1.80M | -1.22M | -1.09M | -971.80K |
| Cash from Operations | -4.02M | -3.38M | -2.74M | -2.54M | -2.35M |
| Capital Expenditure | -- | -1.00K | -2.00K | -2.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | 12.50K | 25.00K | 45.30K | 65.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.25M | -1.09M | -924.60K | -462.30K | -- |
| Cash from Investing | -1.25M | -1.08M | -901.60K | -419.00K | 63.60K |
| Total Debt Issued | 520.60K | 568.50K | 616.40K | 4.15M | 7.69M |
| Total Debt Repaid | -376.60K | -1.17M | -1.96M | -1.94M | -1.92M |
| Issuance of Common Stock | 14.29M | 11.11M | 7.94M | 5.35M | 2.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -33.80K | -67.60K | -101.40K | -135.20K |
| Cash from Financing | 14.43M | 10.48M | 6.53M | 7.47M | 8.40M |
| Foreign Exchange rate Adjustments | 881.80K | 337.90K | -206.00K | -135.60K | -65.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.05M | 6.37M | 2.68M | 4.37M | 6.05M |